The Selective SGLT2 Inhibitor Ipragliflozin Has a Therapeutic Effect on Nonalcoholic Steatohepatitis in Mice

BACKGROUND & AIMS: In recent years, nonalcoholic steatohepatitis (NASH) has become a considerable healthcare burden worldwide. Pathogenesis of NASH is associated with type 2 diabetes mellitus (T2DM) and insulin resistance. However, a specific drug to treat NASH is lacking. We investigated the ef...

Descripción completa

Detalles Bibliográficos
Autores principales: Honda, Yasushi, Imajo, Kento, Kato, Takayuki, Kessoku, Takaomi, Ogawa, Yuji, Tomeno, Wataru, Kato, Shingo, Mawatari, Hironori, Fujita, Koji, Yoneda, Masato, Saito, Satoru, Nakajima, Atsushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4701474/
https://www.ncbi.nlm.nih.gov/pubmed/26731267
http://dx.doi.org/10.1371/journal.pone.0146337

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4701474/
https://www.ncbi.nlm.nih.gov/pubmed/26731267
http://dx.doi.org/10.1371/journal.pone.0146337

Ejemplares similares